President and Chief Executive Officer
Corporate Management
ZEALAND PHARMA
Denmark
Britt joined Zealand as President and CEO in January 2015. Prior to joining Zealand, she headed the Agilent-owned Danish diagnostics Company Dako as the company’s CEO. Britt has extensive experience from a range of managerial positions within the life science industry, including 11 years' international experience with Novo Nordisk. At Novo Nordisk, she held various global leadership positions, including prelaunch commercial project lead, Diabetes Marketing Nordic, Global Diabetes Lifecycle Management, prelaunch commercial projects and, more recently, Corporate Vice President for Global Marketing, Market Access and Commercial Excellence. Previously, Britt worked for McKinsey & Company and within the EU institutions in Brussels.
Life science